Cholamandalam Financial Holdings Ltd
Cholamandalam Financial Holdings Limited (CFHL) is a part of the Murugappa Group. The Co. is a Core Investment Company registered with the RBI, offering a diverse range of financial products and risk management services to individual and corporate customers through its group companies. [1]
- Market Cap ₹ 28,206 Cr.
- Current Price ₹ 1,502
- High / Low ₹ 2,155 / 960
- Stock P/E 13.7
- Book Value ₹ 605
- Dividend Yield 0.04 %
- ROCE 10.7 %
- ROE 19.8 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 20.5% CAGR over last 5 years
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Part of BSE 250 SmallCap Index BSE Diversified Financials Revenue Growth Index (I Nifty Smallcap 250 BSE Allcap BSE SmallCap Select Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7,724 | 8,807 | 9,696 | 8,004 | 2,688 | 8,909 | 10,926 | 13,135 | 13,900 | 14,644 | 18,154 | 25,830 | 29,601 | |
5,422 | 5,991 | 6,542 | 7,029 | 2,377 | 4,490 | 5,147 | 6,588 | 6,807 | 7,210 | 8,597 | 11,389 | 12,700 | |
Operating Profit | 2,302 | 2,815 | 3,154 | 975 | 311 | 4,419 | 5,778 | 6,547 | 7,093 | 7,434 | 9,558 | 14,441 | 16,901 |
OPM % | 30% | 32% | 33% | 12% | 12% | 50% | 53% | 50% | 51% | 51% | 53% | 56% | 57% |
25 | 29 | 123 | 1,538 | 1 | 0 | 21 | 1 | 60 | 92 | 221 | 256 | 277 | |
Interest | 1,520 | 1,896 | 2,103 | 976 | 0 | 2,655 | 3,587 | 4,592 | 4,608 | 4,328 | 5,778 | 9,249 | 10,881 |
Depreciation | 133 | 159 | 171 | 163 | 17 | 70 | 78 | 150 | 145 | 154 | 176 | 248 | 288 |
Profit before tax | 674 | 789 | 1,003 | 1,374 | 295 | 1,695 | 2,135 | 1,806 | 2,400 | 3,044 | 3,824 | 5,200 | 6,009 |
Tax % | 32% | 34% | 32% | 27% | 30% | 34% | 34% | 36% | 27% | 26% | 26% | 26% | |
458 | 518 | 684 | 1,181 | 538 | 1,127 | 1,415 | 1,165 | 1,764 | 2,239 | 2,810 | 3,851 | 4,456 | |
EPS in Rs | 15.45 | 16.66 | 22.68 | 55.47 | 24.26 | 29.32 | 37.12 | 29.34 | 43.93 | 54.49 | 68.71 | 94.39 | 109.39 |
Dividend Payout % | 13% | 12% | 9% | 9% | 1% | 4% | 3% | 2% | 1% | 1% | 1% | 1% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 19% |
3 Years: | 23% |
TTM: | 35% |
Compounded Profit Growth | |
---|---|
10 Years: | 19% |
5 Years: | 21% |
3 Years: | 29% |
TTM: | 34% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 25% |
3 Years: | 29% |
1 Year: | 41% |
Return on Equity | |
---|---|
10 Years: | 18% |
5 Years: | 18% |
3 Years: | 19% |
Last Year: | 20% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 37 | 37 | 37 | 37 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
Reserves | 1,622 | 1,914 | 2,290 | 3,287 | 2,745 | 3,291 | 3,925 | 4,572 | 5,367 | 6,427 | 7,642 | 10,223 | 11,342 |
16,604 | 19,464 | 21,431 | 1,441 | 0 | 38,200 | 50,447 | 55,117 | 63,797 | 69,229 | 97,191 | 134,014 | 157,330 | |
4,837 | 5,887 | 6,579 | 4,900 | 5,129 | 11,897 | 13,546 | 16,147 | 19,432 | 22,097 | 26,181 | 32,662 | 34,987 | |
Total Liabilities | 23,100 | 27,302 | 30,338 | 9,665 | 7,892 | 53,407 | 67,937 | 75,855 | 88,616 | 97,771 | 131,033 | 176,917 | 203,678 |
1,258 | 1,318 | 1,521 | 1,336 | 102 | 311 | 306 | 479 | 447 | 464 | 623 | 1,784 | 1,926 | |
CWIP | 164 | 201 | 40 | 56 | 0 | 4 | 14 | 11 | 10 | 40 | 60 | 13 | 0 |
Investments | 1,688 | 2,116 | 2,665 | 5,141 | 6,536 | 6,211 | 7,552 | 8,893 | 11,678 | 13,282 | 17,536 | 20,058 | 22,463 |
19,990 | 23,667 | 26,112 | 3,131 | 1,254 | 46,881 | 60,065 | 66,472 | 76,481 | 83,984 | 112,813 | 155,063 | 179,288 | |
Total Assets | 23,100 | 27,302 | 30,338 | 9,665 | 7,892 | 53,407 | 67,937 | 75,855 | 88,616 | 97,771 | 131,033 | 176,917 | 203,678 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-3,228 | -1,872 | -1,685 | -500 | 594 | -6,302 | -9,274 | -1,914 | -9,719 | -5,738 | -29,329 | -35,726 | |
-838 | -499 | -461 | 193 | -1,263 | -1,825 | -94 | -96 | -62 | -135 | 295 | -2,625 | |
4,465 | 2,643 | 1,704 | 748 | -69 | 8,287 | 12,171 | 2,427 | 7,688 | 7,073 | 27,288 | 38,269 | |
Net Cash Flow | 398 | 272 | -443 | 441 | -738 | 160 | 2,803 | 417 | -2,093 | 1,199 | -1,746 | -82 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 25 | 25 | 25 | 31 | 32 | 3 | 1 | 1 | 1 | 2 | 2 | 3 |
Inventory Days | 71 | 78 | 87 | 86 | ||||||||
Days Payable | 104 | 135 | 125 | 99 | ||||||||
Cash Conversion Cycle | -8 | -32 | -12 | 18 | 32 | 3 | 1 | 1 | 1 | 2 | 2 | 3 |
Working Capital Days | -14 | -13 | 14 | -90 | -257 | -255 | -225 | -221 | -262 | -284 | -274 | -220 |
ROCE % | 13% | 13% | 13% | 10% | 7% | 18% | 11% | 10% | 10% | 9% | 10% | 11% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 15 Nov
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Transcript of analyst call available on website.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
13 Nov - Cholamandalam Financial Holdings Limited has informed regarding schedule of investor meet.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
8 Nov - Un-audited financial results for Q2 FY2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
8 Nov - Audio recording of earnings call uploaded on website.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
Jun 2020TranscriptPPT
-
Jun 2017TranscriptNotesPPT
-
Nov 2016TranscriptPPT
-
Aug 2016Transcript PPT
-
Apr 2016TranscriptPPT
-
Mar 2016TranscriptNotesPPT
-
Jan 2016TranscriptPPT
Services
NBFC: The Co. provides financial services through its subsidiary Cholamandalam Investment and Finance Company Limited (CIFCL) by offering vehicle finance, home loans, loan against property, etc to a wide range of customers, wherein it holds 45.41% as of June 2022.
General Insurance: The Co. offers a wide range of insurance including motor, travel, health, accident, home, and other types of insurance for corporate customers through its subsidiary Cholamandalam MS General Insurance Company Limited (CMSGICL), wherein it holds 60% as on June 2022.
Risk Management & Engineering Solutions: The Co. provides risk management and engineering solutions in the field of Safety, Health, and Environment through its Joint Venture with Mitsui Sumitomo Insurance Group, Japan through Cholamandalam MS Risk Services Ltd (CMSRSL), wherein it holds 49.5% as on June 2022. [1]